Allianz Asset Management
ALDR

Allianz Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Allianz Asset Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-39,629
Closed -$466K – 2856
2019
Q2 		$466K Sell
39,629
-2,452
-6% -$29.7K ﹤0.01% 2374
2019
Q1 		$575K Buy
42,081
+4,506
+12% +$58.4K ﹤0.01% 2282
2018
Q4 		$384K Buy
37,575
+15,465
+70% +$198K ﹤0.01% 2351
2018
Q3 		$369K Hold
22,110
– – ﹤0.01% 2448
2018
Q2 		$349K Hold
22,110
– – ﹤0.01% 2450
2018
Q1 		$281K Hold
22,110
– – ﹤0.01% 2502
2017
Q4 		$253K Hold
22,110
– – ﹤0.01% 2566
2017
Q3 		$271K Buy
22,110
+1,300
+6% +$13.6K ﹤0.01% 2541
2017
Q2 		$250K Sell
20,810
-290
-1% -$5.36K ﹤0.01% 2544
2017
Q1 		$441K Sell
21,100
-13,061
-38% -$289K ﹤0.01% 2421
2016
Q4 		$711K Sell
34,161
-36,537
-52% -$950K ﹤0.01% 2302
2016
Q3 		$2.29M Buy
70,698
+10,531
+18% +$321K ﹤0.01% 1943
2016
Q2 		$1.5M Buy
60,167
+40,055
+199% +$1.08M ﹤0.01% 2037
2016
Q1 		$492K Buy
20,112
+1,042
+5% +$24.1K ﹤0.01% 2256
2015
Q4 		$644K Hold
19,070
– – ﹤0.01% 2127
2015
Q3 		$625K Sell
19,070
-3,500
-16% -$149K ﹤0.01% 1990
2015
Q2 		$1.2M Buy
+22,570
New +$821K ﹤0.01% 1893

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allianz Asset Management's ALDR Position: Q3 2019 in Review

Allianz Asset Management sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 39,629 shares — an estimated $466K sold.

Allianz Asset Management first reported a position in ALDR in Q2 2015 and held it in 17 quarters. The position peaked at $2.29M in Q3 2016. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

  • Allianz Asset Management reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Allianz Asset Management sold 39,629 Alder Biopharmaceuticals shares in Q3 2019, an estimated $466K.
  • Allianz Asset Management first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 17 quarters.
  • Allianz Asset Management's Alder Biopharmaceuticals position peaked at $2.29M in Q3 2016.
  • 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on Allianz Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.